Xiaflex available for Dupuytren's contracture - ONA

Links shared publicly online about this topic.

  • 1,329
    total visits

Xiaflex available for Dupuytren's contracture - ONA

oncologynurseadvisor.com

BioSpecifics Technologies and Auxilium Pharmaceuticals announced the availability of Xiaflex (collagenase clostridium histolyticum) for the treatment of adult Dupuytren--™s contracture patients with a palpable cord.

View full resource at oncologynurseadvisor.com

Tags: Pharma, Dupuytren Contracture, Hand Disorder

  • Share

Most Recently Shared on March 8, 2010 at 9:37 pm By:

ONAcom OncologyNurseAdvisor

Xiaflex available for Dupuytren's contracture http://goo.gl/fb/bxnr

2 years ago...

Dupuytren's Contracture Treatment, Risk Factors, Causes, Symptoms - MedicineNet

medicinenet.com — “Read about Dupuytren's contracture treatment options: Xiaflex injection, needle aponeurotomy, ultrasound, and cortisone injection. Learn causes, risk factors, and symptoms.View full resource at medicinenet.com

  • View Related
  • Share

Most Recently Shared on March 8, 2012 at 6:49 pm By:

MedicineNet MedicineNet.com Health Site

What are risk factors for a Dupuytren's contracture? http://t.co/c35LB0hf

1 month ago...

Auxilium reports positive data from XIAFLEX retrospective commercial patient chart review

news-medical.net — “Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that positive data from a retrospective commercial patient chart review of XIAFLEX (collagenase clostridium histolyticum) used for the treatment of adult Dupuytren's contracture patients with a palpable cord are available via e-posters at the American Society for Surgery of the Hand meeting in Las Vegas.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 8, 2011 at 1:52 pm By:

NewsMedical News-Medical.Net Health News

Auxilium reports positive data from XIAFLEX retrospective commercial patient chart review: Auxilium Pharma... http://t.co/przKrLZ

7 months ago...

Top-line results from Auxilium XIAFLEX palpable cord study in Dupuytren's contracture subjects

news-medical.net — “Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from a pilot clinical study to assess safety, tolerability, and multiple-dose pharmacokinetics of XIAFLEX (collagenase clostridium histolyticum) in adult Dupuytren's contracture subjects with multiple palpable cords.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 7, 2011 at 1:03 pm By:

NewsMedical News-Medical.Net Health News

Top-line results from Auxilium XIAFLEX palpable cord study in Dupuytren's contracture subjects: Auxilium Pharmac... http://t.co/yPwWthU

7 months ago...

Auxilium, BioSpecifics Technologies to invest in cellulite indication for Xiaflex - Medical Marketing and Media

mmm-online.com — “Auxilium Pharmaceuticals has announced plans to invest in an indication for prescription drug Xiaflex (collagenase clostridium histolyticum), which was approved by FDA in February 2010 for adult Dupuytren's contracture patients with a palpable cord, for the treatment of cellulite.View full resource at mmm-online.com

  • View Related
  • Share

Most Recently Shared on September 2, 2011 at 1:44 am By:

Auxilium, BioSpecifics Technologies to invest in cellulite indication for Xiaflex - Medical Marketing and Media

mmm-online.com — “Auxilium Pharmaceuticals has announced plans to invest in an indication for prescription drug Xiaflex (collagenase clostridium histolyticum), which was approved by FDA in February 2010 for adult Dupuytren's contracture patients with a palpable cord, for the treatment of cellulite.View full resource at mmm-online.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 8:02 pm By:

NickCharles507 Nick Charles Health Marketing

Auxilium, BioSpecifics Technologies to invest in cellulite indication for Xiaflex: Auxilium Pharmaceut... http://t.co/w6SBkR8 from MM&M

7 months ago...

Auxilium reports three year data from XIAFLEX CORDLESS study in Dupuytren's contracture

news-medical.net — “Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced three year recurrence data from the Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study (CORDLESS) for XIAFLEX® (collagenase clostridium histolyticum) in the treatment of adult Dupuytren's contracture patients with a palpable cord.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 30, 2011 at 12:57 pm By:

NewsMedical News-Medical.Net Health News

Auxilium reports three year data from XIAFLEX CORDLESS study in Dupuytren's contracture: Auxilium Pharmaceutical... http://bit.ly/m1Xn0c

10 months ago...

Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytren's Contracture - Drugs.com MedNews

drugs.com — “- Nominal Recurrence Rate of 34.8 at Three Years for Joints Previously Treated Successfully with XIAFLEX -93 of joints that were successfully treated with XIAFLView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 30, 2011 at 12:17 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytren's Contrac... http://bit.ly/k0qSW2 #drug

10 months ago...

Xiapex: New option for Dupuytren's contracture | MIMS online

mims.co.uk — “Xiapex has been launched as treatment for Dupuytren's contracture. Treatment for Dupuytren's contracture without surgery.View full resource at mims.co.uk

  • View Related
  • Share

Most Recently Shared on May 6, 2011 at 10:02 am By:

mimsonline MIMS Online Medical Publisher

First injectable treatment for Dupuytren's contracture available: http://bit.ly/mTxcJ4

11 months ago...

Xiapex(R) (Collagenase Clostridium Histolyticum), First Injectable Treatment Indicated For Dupuytren's Contracture, Launched In UK

medicalnewstoday.com — “Xiapex® (collagenase clostridium histolyticum), the first licensed injectable treatment option for Dupuytren's contracture in adult patients with a palpable cord, is now available in the UK.1View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 5, 2011 at 12:05 pm By:

mnt_dermatology MNT Dermatology News Dermatology and Health News

Xiapex(R) (Collagenase Clostridium Histolyticum), First Injectable Treatment Indicated For Dupuytren's Contracture, La... http://mnt.to/3TbH

1 year ago...

New Treatment Unlocks Curled Fingers

newswise.com — “A new, nonsurgical treatment now is available for Dupuytren's contracture, a debilitating condition that curls fingers toward the palm.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on January 25, 2011 at 11:24 pm By:

newswise newswise Health Communicator and Health News

Most Emailed: New Treatment Unlocks Curled Fingers: A new, nonsurgical treatment now is available for Dupuytren'... http://bit.ly/giIALN

1 year ago...

New Treatment Unlocks Curled Fingers

newswise.com — “A new, nonsurgical treatment now is available for Dupuytren's contracture, a debilitating condition that curls fingers toward the palm.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on January 18, 2011 at 3:25 pm By:

newswise newswise Health Communicator and Health News

New Treatment Unlocks Curled Fingers: A new, nonsurgical treatment now is available for Dupuytren's contracture,... http://bit.ly/gDBdGb

1 year ago...

XIAFLEX® Effective In Nonsurgically Treating MP And PIP Joints With Dupuytren's Contractures In Second Pivotal Study

medicalnewstoday.com — “Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, announced that The Journal of Hand Surgery (JHS) has published in its December online edition the Company's pView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 7, 2010 at 4:05 pm By:

mnt_bones MNT Bones/Orthopedic Health News

XIAFLEX® Effective In Nonsurgically Treating MP And PIP Joints With Dupuytren's Contractures In Second Pivotal Study http://mnt.to/3NG4

1 year ago...

XIAFLEX Effective in Nonsurgically Treating MP and PIP Joints with Dupuytren's Contractures in Second Pivotal Study - Drugs.com MedNews

drugs.com — “XIAFLEX CORD II Study Published in The Journal of Hand Surgery MALVERN, Pa., Dec. 6, 2010 PRNewswire-FirstCall Auxilium Pharmaceuticals, Inc. (Nasdaq AUXL), a sView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on December 6, 2010 at 2:07 pm By:

Drugs_Devices Drugs and Devices OW OW Health

XIAFLEX Effective in Nonsurgically Treating MP and PIP Joints with Dupuytren's Contractures in Second Pivo... http://bit.ly/grf0RZ #drug

1 year ago...

BioSpecifics' partner Auxilium provides update on XIAFLEX

news-medical.net — “BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its strategic partner Auxilium Pharmaceuticals, Inc. has provided an update on XIAFLEX, its injectable collagenase product currently marketed in the U.S. for the treatment of Dupuytren's contracture.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 13, 2010 at 4:40 am By:

NewsMedical News-Medical.Net Health News

BioSpecifics' partner Auxilium provides update on XIAFLEX: BioSpecifics Technologies Corp., a biopharmaceutical co... http://bit.ly/bX3VKh

2 years ago...

Auxilium Announces U.S. Food and Drug Administration Approval for Xiaflex for the Treatment of Dupuytren's Contracture

drugs.com — “Xiaflex (collagenase clostridium histolyticum) is used to treat Dupuytren's contracture. Includes Xiaflex side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on February 3, 2010 at 10:07 pm By:

drugscom Drugs.com Health Site

Auxilium Announces FDA Approval for Xiaflex for the Treatment of Dupuytren's Contracture - http://bit.ly/cV10Uc

2 years ago...

Advertisement